Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States

BACKGROUND: The prevalence of antimicrobial resistance among gram-negative pathogens in complicated intra-abdominal infections (cIAIs) has increased. In the absence of timely information on the infecting pathogens and their susceptibilities, local or regional epidemiology may guide initial empirical...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhu, Vimalanand S., Solomkin, Joseph S., Medic, Goran, Foo, Jason, Borse, Rebekah H., Kauf, Teresa, Miller, Benjamin, Sen, Shuvayu S., Basu, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658949/
https://www.ncbi.nlm.nih.gov/pubmed/29090091
http://dx.doi.org/10.1186/s13756-017-0264-2

Ejemplares similares

Ejemplares similares